| 13 | Eli Lilly and CompanyLLY | 🇺🇸 USA | Healthcare | $1.20 T | $65.2 B | 50,000 | +104.3% |
| 23 | Johnson & JohnsonJNJ | 🇺🇸 USA | Healthcare | $652.5 B | $94.2 B | 138,200 | +68.4% |
| 26 | AbbVie Inc.ABBV | 🇺🇸 USA | Healthcare | $514.0 B | $61.2 B | 57,000 | +80.3% |
| 40 | Merck & Co., Inc.MRK | 🇺🇸 USA | Healthcare | $359.8 B | $65.0 B | 75,000 | +21.3% |
| 70 | Thermo Fisher Scientific Inc.TMO | 🇺🇸 USA | Healthcare | $253.8 B | $44.6 B | 125,000 | +22.2% |
| 73 | Amgen Inc.AMGN | 🇺🇸 USA | Healthcare | $249.2 B | $36.8 B | 25,200 | +53.6% |
| 104 | Gilead Sciences, Inc.GILD | 🇺🇸 USA | Healthcare | $193.5 B | $29.4 B | 17,000 | +83.9% |
| 117 | Abbott LaboratoriesABT | 🇺🇸 USA | Healthcare | $181.1 B | $44.3 B | 115,000 | -6.0% |
| 127 | Pfizer Inc.PFE | 🇺🇸 USA | Healthcare | $170.7 B | $62.6 B | 75,000 | +1.7% |
| 171 | Vertex Pharmaceuticals IncorporatedVRTX | 🇺🇸 USA | Healthcare | $134.3 B | $12.0 B | 6,400 | +25.2% |
| 181 | Bristol-Myers Squibb CompanyBMY | 🇺🇸 USA | Healthcare | $125.5 B | $48.2 B | 32,500 | +17.9% |
| 200 | McKesson CorporationMCK | 🇺🇸 USA | Healthcare | $115.5 B | $403.4 B | 43,000 | +80.8% |
| 302 | Regeneron Pharmaceuticals, Inc.REGN | 🇺🇸 USA | Healthcare | $84.1 B | $14.3 B | 15,410 | -15.9% |
| 427 | Cencora, Inc.COR | 🇺🇸 USA | Healthcare | $59.9 B | $321.3 B | 51,000 | +41.5% |
| 439 | Cardinal Health, Inc.CAH | 🇺🇸 USA | Healthcare | $58.1 B | $254.2 B | 63,900 | +123.5% |
| 572 | IQVIA Holdings Inc.IQV | 🇺🇸 USA | Healthcare | $45.1 B | $16.3 B | 86,000 | +12.3% |
| 619 | IDEXX Laboratories, Inc.IDXX | 🇺🇸 USA | Healthcare | $41.5 B | $4.3 B | 10,780 | -7.1% |
| 790 | Zoetis Inc.ZTS | 🇺🇸 USA | Healthcare | $32.9 B | $9.5 B | 1,700 | -63.0% |
| 853 | Alnylam Pharmaceuticals, Inc.ALNY | 🇺🇸 USA | Healthcare | $30.1 B | $3.7 B | 2,500 | +24.6% |
| 918 | West Pharmaceutical Services, Inc.WST | 🇺🇸 USA | Healthcare | $27.1 B | $3.1 B | 10,800 | +7.6% |
| 1045 | Incyte CorporationINCY | 🇺🇸 USA | Healthcare | $23.8 B | $5.1 B | 2,844 | +59.5% |
| 1677 | Neurocrine Biosciences, Inc.NBIX | 🇺🇸 USA | Healthcare | $13.9 B | $2.9 B | 1,200 | +5.6% |
| 1790 | Baxter International Inc.BAX | 🇺🇸 USA | Healthcare | $12.9 B | $11.2 B | 37,500 | -34.2% |
| 2023 | Madrigal Pharmaceuticals, Inc.MDGL | 🇺🇸 USA | Healthcare | $11.1 B | $958 M | 915 | +157.2% |
| 2053 | BioMarin Pharmaceutical Inc.BMRN | 🇺🇸 USA | Healthcare | $10.8 B | $3.2 B | 3,221 | -41.3% |
| 2406 | Arrowhead Pharmaceuticals, Inc.ARWR | 🇺🇸 USA | Healthcare | $8.7 B | $451 M | 711 | +134.3% |
| 2786 | Ionis Pharmaceuticals, Inc.IONS | 🇺🇸 USA | Healthcare | $7.1 B | $944 M | 1,402 | -3.4% |
| 2900 | Amneal Pharmaceuticals, Inc.AMRX | 🇺🇸 USA | Healthcare | $6.7 B | $3.0 B | 8,500 | +270.8% |
| 3142 | Rhythm Pharmaceuticals, Inc.RYTM | 🇺🇸 USA | Healthcare | $6.0 B | $190 M | 414 | +131.8% |
| 3163 | Ligand Pharmaceuticals IncorporatedLGND | 🇺🇸 USA | Healthcare | $5.9 B | $268 M | 47 | +384.6% |
| 4633 | Acadia Pharmaceuticals Inc.ACAD | 🇺🇸 USA | Healthcare | $3.4 B | $1.1 B | 513 | -30.6% |
| 5225 | Supernus Pharmaceuticals, Inc.SUPN | 🇺🇸 USA | Healthcare | $2.8 B | $719 M | 575 | +84.4% |
| 5608 | Biohaven Pharmaceutical Holding CompanyBHVN | 🇺🇸 USA | Healthcare | $2.5 B | — | 797 | -26.7% |
| 6241 | Sarepta Therapeutics, Inc.SRPT | 🇺🇸 USA | Healthcare | $2.1 B | $2.2 B | 1,162 | -76.6% |
| 6328 | Agios Pharmaceuticals, Inc.AGIO | 🇺🇸 USA | Healthcare | $2.0 B | $54 M | 392 | +49.6% |
| 7162 | Ultragenyx Pharmaceutical Inc.RARE | 🇺🇸 USA | Healthcare | $1.6 B | $673 M | 1,119 | -58.4% |
| 7172 | ANI Pharmaceuticals, Inc.ANIP | 🇺🇸 USA | Healthcare | $1.6 B | $883 M | 601 | +42.4% |
| 8185 | Nektar TherapeuticsNKTR | 🇺🇸 USA | Healthcare | $1.3 B | $55 M | 740 | +1086.4% |
| 8923 | Amphastar Pharmaceuticals, Inc.AMPH | 🇺🇸 USA | Healthcare | $1.1 B | $720 M | 1,761 | -64.1% |
| 11793 | Ironwood Pharmaceuticals, Inc.IRWD | 🇺🇸 USA | Healthcare | $599 M | $296 M | 219 | -69.1% |
| 13835 | Fennec Pharmaceuticals Inc.FENC | 🇺🇸 USA | Healthcare | $374 M | $45 M | 35 | +35.5% |
| 14325 | Enanta Pharmaceuticals, Inc.ENTA | 🇺🇸 USA | Healthcare | $334 M | $65 M | 155 | +31.7% |
| 15126 | Rocket Pharmaceuticals, Inc.RCKT | 🇺🇸 USA | Healthcare | $274 M | $0 M | 151 | -89.4% |
| 15636 | Vanda Pharmaceuticals Inc.VNDA | 🇺🇸 USA | Healthcare | $238 M | $216 M | 278 | -3.2% |
| — | Alexion Pharmaceuticals, Inc.ALXNUnlisted | 🇺🇸 USA | Healthcare | $39.0 B (Jan 2022) | $6.1 B | 3,837 | — |
| — | Reata PharmaceuticalsRETAUnlisted | 🇺🇸 USA | Healthcare | $6.3 B (Jul 2023) | $2 M | 323 | — |
| — | Eidos Therapeutics6MX.MU | 🇺🇸 USA | Healthcare | $5.8 B (Jan 2021) | $27 M | 70 | — |
| — | McKesson Europe AGCLS1.HM | 🇩🇪 Germany | Healthcare | $5.4 B (Jan 2024) | $10.1 B | 80,000 | — |
| — | Arena PharmaceuticalsARNAUnlisted | 🇺🇸 USA | Healthcare | $5.7 B (Jan 2022) | $0 M | 363 | — |
| — | Blueprint Medicines CorporationBPMCUnlisted | 🇺🇸 USA | Healthcare | $5.4 B (Jan 2024) | $204 M | 383 | — |